84
43
Growth Score 84 in past quarter
-3 pts
Heat Score 43 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2791474
Musli Thyropeutics is a pharmaceutical company that specializes in developing a combination of re-purposed drugs for cancer treatment.
- Offer Fabian: CEOPast Role: InSightec, VP Commercial Development
About the Company
Musli Thyropeutics is a pharmaceutical company that specializes in developing a combination of repurposed drugs for cancer treatment. It focuses on glioblastoma multiforme and brain metastases from lung and other cancers and other aggressive cancers.
The company was founded in 2014 and headquartered in HaMerkaz, Israel.